MedPath

Prophylactic Negative Pressure Wound Therapy for High Risk Laparotomy Wounds. A Randomized Prospective Clinical Trial.

Not Applicable
Terminated
Conditions
Surgical Wound
Surgical Site Infection
Dehiscence of Internal Surgical Wound
Wound Dehiscence, Surgical
Interventions
Device: Prophylactic negative pressure wound dressing after laparotomy
Registration Number
NCT03716687
Lead Sponsor
St. Borbala Hospital
Brief Summary

Negative pressure wound closure technique (NPWT) has been widely introduced in different clinical settings. Most of the studies report it as an effective and cost-effective method to treat complicated surgical wounds or even open abdomen.

NPWT as a prophylactic effort to prevent complications of high risk surgical wounds has recently been introduced, but the concept is still lacking clinical evidence in terms of clinical effectiveness and cost effectiveness.

In this randomized, multi centric study investigators aim to compare prophylactic negative pressure wound closure (ciNPWT) with traditional, dry wound dressing at high infection risk laparotomy wounds.

Detailed Description

The aim is to compare ciNPWT (closed incisional negative pressure wound dress) technique to the traditional, dry wound dressing technique at high infection risk laparotomy wounds.

Control arm will be treated "as usual": sterile gauze or high-absorbing surgical wound dress.

Experimental arm will be dressed with: one layer of silver-containing, impregnated mesh laxer (Atrauman® Ag - Hartmann) directly placed on the primary closed wound, one layer of alcohol-soaked foam (VivanoMed® White Foam - Hartmann) and sufficient-size sealant film (Hydrofilm® - Hartmann).

A negative pressure of -90 Hgmm will be administered in a continuous mode over 5 days postoperatively.

Surgical site infection and abdominal wall dehiscence rate will be assessed, as well as cost effectiveness will be calculated at both arms.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • High risk laparotomy patients. SSI risk at least 3x higher than normal rate (6-8%)
  • Surgical wound type III or IV..
Exclusion Criteria
  • Patients not giving informed consent.
  • Patients requiring open abdominal wound care.
  • Patients with abdominal wall malignancy,
  • Patients with peritoneal carcinomatosis,
  • Patients who are planned for second look laparotomy within 5 days,
  • Patients with less thank 3 month life expectancy.
  • Patients who are operated with existing wound infection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ciNPWTProphylactic negative pressure wound dressing after laparotomyProphylactic negative pressure wound dress (Hartmann) is set up for 5 days right after operation. Continous -90 Hgmm negative pressure mode selected. No change of wound dress until 5 days completed.
Primary Outcome Measures
NameTimeMethod
Surgical site infection30 days

Surgical site infection requiring wound re-opening (suture removal) and open wound treatment. (Clavien-Dindo 2)

Secondary Outcome Measures
NameTimeMethod
Full thickness abdominal wall dehiscence, requiring re-operation30 days

Full thickness abdominal wall dehiscence, requiring re-operation

Trial Locations

Locations (1)

St. Borbala Hospital

🇭🇺

Tatabánya, Hungary

© Copyright 2025. All Rights Reserved by MedPath